Lactulose Pharmacology

Lactulose, an osmotic laxative, serves a critical role in managing hepatic encephalopathy and cirrhosis by reducing toxic ammonia levels in the bloodstream. While it functions by drawing water into the gastrointestinal tract, its primary clinical application involves bacterial breakdown in the gut, which creates an acidic environment that converts ammonia into the non-absorbable, ionized form NH4+. This process facilitates the excretion of ammonia through feces. Effective dosing requires titration to achieve two to three soft stools daily, balancing symptom management with patient comfort. Clinicians must monitor for adverse effects like bloating and diarrhea, while remaining vigilant for potential drug interactions, particularly with warfarin or medications that exacerbate constipation or elevate ammonia levels, such as valproic acid. Regular assessment of patient medication lists remains essential to avoid compounding these underlying conditions.